Cetirizine Dihydrochloride Price Trend 2026: Market Analysis, Chart and Forecast
According to ChemAnalyst, The Cetirizine Dihydrochloride Prices recorded a firm upward movement during the second quarter of 2026, with prices increasing across North America, Asia-Pacific (APAC), and Europe. The market was supported primarily by stronger seasonal demand for antihistamine medicines, improved procurement activity from pharmaceutical manufacturers, and higher logistics and freight costs.
Cetirizine Dihydrochloride is a widely used active pharmaceutical ingredient (API) in antihistamine formulations designed to manage allergic conditions such as allergic rhinitis, urticaria, and other allergy-related symptoms. Because demand for cetirizine-based medicines tends to increase during periods of heightened seasonal allergies, procurement activity can influence API prices significantly.
During Q2 2026, the United States market registered the strongest price increase among the three assessed regions, while China and Germany also experienced notable quarterly gains. The combination of seasonal pharmaceutical demand, export activity, transportation expenses, and changing purchasing patterns contributed to the overall firming trend.
Cetirizine Dihydrochloride Prices in North America
In North America, the Cetirizine Dihydrochloride Price Index in the USA increased by 8.33% quarter-over-quarter during Q2 2026. The increase was primarily associated with stronger seasonal buying as pharmaceutical manufacturers and distributors increased procurement ahead of higher demand for allergy-related medicines.
The average Cetirizine Dihydrochloride price in the United States was approximately USD 211,941.67/MT CFR during the quarter. The comparatively high price level reflected a combination of firm API demand, procurement requirements, and international logistics expenses.
Seasonal demand played an important role in the US market. Cetirizine is extensively incorporated into over-the-counter and prescription allergy medications, and demand for these products can rise during periods associated with increased pollen and allergy incidence. Pharmaceutical companies and distributors therefore tend to strengthen inventory positions to ensure product availability.
Another contributing factor was purchasing activity across the pharmaceutical supply chain. Buyers seeking to secure sufficient quantities may increase order volumes or bring forward procurement schedules when they anticipate stronger downstream consumption. This can tighten near-term availability and provide support to API prices.
Freight and import-related costs also remained relevant to the CFR-based market assessment. Higher transportation expenses can increase the landed cost of imported APIs, particularly when pharmaceutical companies rely on overseas suppliers.
Overall, the US market remained firm during Q2 2026, with the 8.33% quarter-over-quarter increase demonstrating the impact of seasonal pharmaceutical demand and supply-chain costs on Cetirizine Dihydrochloride Prices.
Get Real Time Online for Cetirizine Dihydrochloride Prices: https://www.chemanalyst.com/Pricing-data/cetirizine-dihydrochloride-1695
Cetirizine Dihydrochloride Prices in APAC
The APAC market also experienced a substantial increase during Q2 2026. In China, the Cetirizine Dihydrochloride Price Index increased by 7.18% quarter-over-quarter, supported by stronger export offers directed toward European markets.
The average Cetirizine Dihydrochloride price in China was approximately USD 208,113.67/MT CFR Shanghai.
China remains an important manufacturing and export hub for pharmaceutical ingredients, making export demand an important factor in domestic and regional price formation. During Q2, firmer European buying interest contributed to stronger export offers, which subsequently supported the overall pricing environment.
The increase also reflected the relationship between international demand and producer pricing strategies. When overseas buyers demonstrate stronger purchasing requirements, suppliers may revise offers upward, particularly when available production capacity is relatively balanced with demand.
Seasonal pharmaceutical consumption in international markets provided additional support. As demand for antihistamine products increased, pharmaceutical manufacturers and distributors sought to maintain sufficient inventories. This encouraged additional sourcing activity from API suppliers.
The Chinese market therefore remained closely connected with global pharmaceutical demand. Changes in export orders, freight costs, manufacturing expenses, and inventory requirements all influenced the movement of Cetirizine Dihydrochloride Prices during the quarter.
The 7.18% quarterly increase indicates that China's market remained firmly positioned despite differences in procurement conditions between domestic and export-oriented buyers.
Cetirizine Dihydrochloride Prices in Europe
Germany also recorded a notable increase in Cetirizine Dihydrochloride Prices during Q2 2026. The German Cetirizine Dihydrochloride Price Index rose by 7.93% quarter-over-quarter, reflecting seasonal freight pressures and stronger pharmaceutical procurement requirements.
The average price was approximately USD 211,455.67/MT CFR Hamburg delivered during the quarter.
The European market was influenced by both downstream pharmaceutical demand and logistics conditions. Seasonal requirements for allergy medications supported purchasing activity, while freight-related expenses contributed to higher delivered prices.
Germany's position as a major pharmaceutical manufacturing and distribution market also makes it sensitive to changes in international API availability. Pharmaceutical companies generally prioritize reliable supply because disruptions in active ingredients can affect downstream production schedules.
During Q2 2026, higher logistics expenses added pressure to delivered costs. For imported pharmaceutical ingredients, transportation, insurance, handling, and port-related expenses can influence the final landed price. These factors became particularly relevant as seasonal buying strengthened.
European procurement activity also contributed to stronger supplier offers. Buyers looking to secure supply during a period of rising seasonal demand may accept higher prices to maintain inventory continuity. This dynamic supported the upward movement in the German market.
Key Factors Influencing Cetirizine Dihydrochloride Prices
Several factors shaped the Cetirizine Dihydrochloride Prices during Q2 2026.
Seasonal Allergy-Medicine Demand
Seasonality was one of the most important demand-side drivers. Cetirizine is widely used in products targeting allergy symptoms, meaning consumption can increase during periods of elevated seasonal allergies.
Pharmaceutical manufacturers typically plan inventories ahead of anticipated demand. Increased procurement from manufacturers and distributors can therefore create additional pressure on API availability.
Pharmaceutical Manufacturing Activity
The level of pharmaceutical production directly affects API demand. Higher manufacturing activity for antihistamine formulations can increase requirements for Cetirizine Dihydrochloride.
When pharmaceutical companies increase production schedules, they may place larger or more frequent API orders, providing support to supplier pricing.
Export Demand from China
China's importance as a pharmaceutical ingredient manufacturing and export center made international demand a key factor during Q2. Stronger European export offers contributed to the 7.18% quarter-over-quarter increase in China's Cetirizine Dihydrochloride Price Index.
Export-oriented suppliers can adjust quotations depending on overseas demand, freight conditions, and available production capacity.
Freight and Logistics Costs
Transportation expenses remained another important factor. CFR and delivered prices incorporate logistics considerations, meaning increases in freight rates can directly affect the final cost paid by buyers.
Germany's 7.93% quarterly price increase was partly associated with seasonal freight pressures, highlighting the role of logistics in the European market.
Inventory Management
Inventory strategies can have a considerable short-term impact on API prices. When buyers anticipate higher downstream demand, they may build inventories earlier than usual. Such purchasing can tighten spot availability and strengthen supplier negotiating positions.
Conversely, if buyers hold sufficient inventories and reduce new purchases, price momentum can weaken.
Regional Comparison of Cetirizine Dihydrochloride Prices
The Q2 2026 market showed relatively consistent upward movement across all three assessed regions.
Region | Q2 2026 Price Index Change | Average Price | Basis |
USA | +8.33% QoQ | USD 211,941.67/MT | CFR |
China | +7.18% QoQ | USD 208,113.67/MT | CFR Shanghai |
Germany | +7.93% QoQ | USD 211,455.67/MT | CFR Hamburg Delivered |
The United States recorded the largest quarterly increase at 8.33%, followed by Germany at 7.93% and China at 7.18%. Despite differences in regional demand and supply conditions, all three markets demonstrated a firm pricing trajectory.
The relatively close average price levels also indicate that international market conditions, including pharmaceutical demand and logistics costs, were influencing regional price formation.
Supply-Demand Outlook for Cetirizine Dihydrochloride
The supply-demand balance is expected to remain an important factor for Cetirizine Dihydrochloride Prices through the remainder of 2026. Demand conditions will largely depend on pharmaceutical production schedules, seasonal allergy trends, inventory levels, and purchasing behavior.
If pharmaceutical manufacturers continue to replenish inventories following the Q2 seasonal demand increase, suppliers could maintain relatively firm offers. Strong export demand from China could also provide additional support to international prices.
On the supply side, production availability, raw-material costs, operating rates, and transportation conditions will remain important. Any unexpected production disruptions or logistical bottlenecks could tighten availability and create additional upward price pressure.
However, if seasonal demand gradually moderates and buyers move toward inventory normalization, the market could experience more balanced conditions. In such a scenario, the rate of price increases may slow.
Cetirizine Dihydrochloride Price Forecast 2026
The Cetirizine Dihydrochloride price forecast for 2026 points toward a market that may remain relatively firm in the near term, although the pace of appreciation could depend on the continuation of seasonal demand and international procurement activity.
North American prices are likely to remain supported if pharmaceutical companies maintain strong purchasing requirements. In APAC, export demand and supplier quotations will remain key indicators to monitor, particularly in China.
In Europe, freight and delivered logistics costs could continue to influence the market. Germany's position as a major pharmaceutical market means changes in procurement activity could have a measurable impact on regional pricing.
The market could stabilize if seasonal demand begins to normalize, inventories improve, and logistics costs become more manageable. Conversely, stronger-than-expected pharmaceutical consumption or supply disruptions could result in additional price increases.
Book A Demo for Cetirizine Dihydrochloride Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Cetirizine%20Dihydrochloride
Conclusion
The Cetirizine Dihydrochloride Prices market demonstrated broad-based growth during Q2 2026. The USA recorded an 8.33% quarter-over-quarter increase, reaching an average price of USD 211,941.67/MT CFR. China recorded a 7.18% increase, with an average price of USD 208,113.67/MT CFR Shanghai, while Germany registered a 7.93% increase, reaching approximately USD 211,455.67/MT CFR Hamburg delivered.
The primary factors behind the increase included stronger seasonal pharmaceutical demand, higher procurement activity, export offers, and freight-related pressures. With antihistamine demand remaining an important downstream driver, market participants will continue monitoring pharmaceutical production, inventory levels, export activity, logistics costs, and supplier availability.
Overall, the Q2 2026 trend indicates a firm Cetirizine Dihydrochloride market, while the direction of prices during the rest of 2026 will depend on the balance between seasonal demand normalization and continued pharmaceutical procurement.
About Us:
Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.
Contact Us:
Address:
420 Lexington Avenue, Suite 300 New York, NY 10170 United States
Phone: +1 332 258 6602
Email: sales@chemanalyst.com
Website: https://www.chemanalyst.com/
LinkedIn: https://www.linkedin.com/company/chemanalyst/
Facebook: https://www.facebook.com/ChemAnalysts/
Twitter: https://x.com/chemanalysts
YouTube: https://www.youtube.com/@chemanalyst
Instagram: https://www.instagram.com/chemanalyst_
Comments
Post a Comment